ArticleFrontiers in digital health2026
Structuring medication safety narratives: development and evaluation of the medication-related incident reports annotation scheme.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Narrative reports of medication-related incidents contain valuable information about the causes and consequences of errors, but their unstructured format limits systematic analysis. Although natural language processing (NLP) can convert narrative reports into structured data, few annotation schemes have been developed specifically for medication safety and validated using real-world healthcare incident data. This study aimed to develop and evaluate the Medication-Related Incident Report Annotation (MRIRA) scheme, a multi-layer framework designed to structure narrative medication safety reports to support both qualitative analysis and automated text processing. Methods: Using narrative incident reports from the English National Health Service (NHS), a two-phase study design was implemented. In Phase 1, a purposive sample of 55 Controlled Drug incident reports was manually annotated to iteratively design the MRIRA scheme. The framework incorporated multiple annotation layers, including entities, events, attributes, and relations. The final scheme comprised 16 entity types, 11 event types, 5 attributes, 9 relation types, and 6 event argument roles. In Phase 2, two annotators independently applied the scheme to 30 incident reports, including 15 Controlled Drug reports and 15 reports from the National Reporting and Learning System/Learn from Patient Safety Events (NRLS/LFPSE). Inter-annotator agreement was evaluated using F1 scores under both strict and relaxed matching criteria. Results: Under strict evaluation, agreement was high for entity recognition (F1 = 0.85 and 0.91 across the two datasets) and entity-relation extraction (0.75 and 0.83). Agreement was moderate for event extraction (0.62 and 0.72) and acceptable for event attribute tagging (0.61 and 0.51). All metrics improved under relaxed matching criteria, indicating greater consistency when allowing minor boundary variation between annotations. Discussion: The MRIRA scheme provides a robust and reliable framework for structuring narrative medication safety reports. By enabling systematic extraction of entities, events, and contextual relationships from incident narratives, the scheme offers a high-quality annotated resource that can support the development of automated NLP tools and enhance organisational learning from medication-related incidents in healthcare systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.